A Study of Bevacizumab Added to Trastuzumab Plus Docetaxel in the Neoadjuvant Setting in Participants With Early Stage HER2-Positive Breast Cancer
Clinical trial NCT01142778 · COMPLETED
Trial details
- NCT number
- NCT01142778
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-05-19
- Primary completion
- 2017-12-13
- Enrollment
- 152
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.